Clinical Trial Update: A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• ONO-4641

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED